Eduardo Flavio Oliveira Ribeiro
@eduardoflavio.bsky.social
Hematologist in Brasilia/Brasil
Lymphoma, Leukemia and Myeloma doc
Daddy, Husband, Lactose Tolerant and addicted to good music, History and arts
Lymphoma, Leukemia and Myeloma doc
Daddy, Husband, Lactose Tolerant and addicted to good music, History and arts
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia | New England Journal of Medicine www.nejm.org/doi/full/10.... There’s some interesting points here.
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia | NEJM
To the Editor: Brown et al. (Feb. 20 issue)1 report the results of the AMPLIFY trial, in which fixed-duration acalabrutinib–venetoclax, with or without obinutuzumab, was compared with chemoimmunoth...
www.nejm.org
June 5, 2025 at 11:29 AM
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia | New England Journal of Medicine www.nejm.org/doi/full/10.... There’s some interesting points here.
This is the best review published this year about CLL available data and current perspective on choosing therapies and what to expect from ongoing trials. Kudos for the authors. ascopubs.org/doi/full/10....
When and How Long to Treat Chronic Lymphocytic Leukemia?
Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases
treated with allogeneic stem-cell transplantation or favorable-risk CLL treated with
chemoimmunotherapy. Treatment...
ascopubs.org
May 24, 2025 at 4:03 PM
This is the best review published this year about CLL available data and current perspective on choosing therapies and what to expect from ongoing trials. Kudos for the authors. ascopubs.org/doi/full/10....
rdcu.be/ehbO9 This is how the Clinical Practice overcome hurdles for offering the best, or the possible best, to our patients. Great!
Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients
Blood Cancer Journal - Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients
rdcu.be
April 10, 2025 at 11:22 AM
rdcu.be/ehbO9 This is how the Clinical Practice overcome hurdles for offering the best, or the possible best, to our patients. Great!
Reposted by Eduardo Flavio Oliveira Ribeiro
Remember that to amplify your post on the sky, you need to share posts that you like.
a cartoon dog wearing headphones and a bow tie is pressing a share button
Alt: a cartoon dog wearing headphones and a bow tie is pressing a share button
media.tenor.com
February 11, 2025 at 11:53 AM
Remember that to amplify your post on the sky, you need to share posts that you like.
Actually, Greenland is mine!
January 25, 2025 at 9:34 PM
Actually, Greenland is mine!
Reposted by Eduardo Flavio Oliveira Ribeiro
Hello, #hematology community! ASH is now on BlueSky.
We're here to share cutting-edge research and educational resources and connect global experts in blood diseases.
Join us in advancing hematology together. Welcome, colleagues!
#BloodSky #HemeSky #MedSky
We're here to share cutting-edge research and educational resources and connect global experts in blood diseases.
Join us in advancing hematology together. Welcome, colleagues!
#BloodSky #HemeSky #MedSky
November 21, 2024 at 5:15 PM
Hello, #hematology community! ASH is now on BlueSky.
We're here to share cutting-edge research and educational resources and connect global experts in blood diseases.
Join us in advancing hematology together. Welcome, colleagues!
#BloodSky #HemeSky #MedSky
We're here to share cutting-edge research and educational resources and connect global experts in blood diseases.
Join us in advancing hematology together. Welcome, colleagues!
#BloodSky #HemeSky #MedSky